Simplified biorelevant media for screening dissolution performance of poorly soluble drugs

Dissolution Technologies

Volumn 14, Issue 4, 2007, Pages 8-13

  Zoeller, Thomas ^a   Klein, Sandra ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; KETOCONAZOLE; PHOSPHATIDYLCHOLINE; TAMOXIFEN CITRATE; TAUROCHOLIC ACID;

ANALYTICAL EQUIPMENT; ARTICLE; BIOCHEMICAL ANALYSIS; BIORELEVANT MEDIUM; BUFFER CAPACITY; CONTROLLED STUDY; DEVICE MATERIAL; DIGESTIVE TRACT PARAMETERS; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SOLUBILITY; FASTED STATE SIMULATED INTESTINAL FLUID; FED STATE SIMULATED INTESTINAL FLUID; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTESTINE FLUID; OSMOLALITY; PH; PHYSICAL CHEMISTRY; SURFACE TENSION;

EID: 84962094390     PISSN: 1521298X     EISSN: None     Source Type: Journal    
DOI: 10.14227/DT140407P8     Document Type: Article

References (14)

1. Galia, E.; Nicolaides, E.; Hörter, D.; Löbenberg, R.; Reppas, C.; Dressman, J. B. Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs. Pharm. Res. 1998, 15 (5), 698-705.
2. Nicolaides, E.; Galia, E.; Efthymiopoulos, C.; Dressman, J. B.; Reppas, C. Forecasting the in vivo performance of four low solubility drugs from their in vitro dissolution data. Pharm. Res. 1999, 16 (12), 1876-1882.
3. Dressman, J. B.; Reppas, C. In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 2000, 11 (Suppl 2), 73-80.
4. Kostewicz, E. S.; Brauns, U.; Becker, R.; Dressman, J. B. Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media. Pharm. Res. 2002, 19 (3), 345-349.
5. Nicolaides, E.; Hempenstall, J. M.; Reppas, C. Biorelevant Dissolution Tests with Flow-Through Apparatus. Dissolution Technol. 2000, 7 (1), 8-11.
6. Nicolaides, E.; Symillides, M.; Dressman, J. B.; Reppas, C. Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration. Pharm. Res. 2001, 18 (3), 380-388.
7. Wei, H.; Lobenberg, R. Biorelevant dissolution media as a predictive tool for glyburide a class II drug. Eur. J. Pharm. Sci. 2006, 29 (1), 45-52.
8. Buchanan, C. M., Buchanan, N. L.; Edgar, K. J.; Little, J. L.; Malcolm, M. O.; Ruble, K. M.; Wacher, V. J.; Wempe, M. F. Pharmacokinetics of tamoxifen after intravenous and oral dosing of tamoxifen-hydroxybutenyl-betacyclodextrin formulations. J. Pharm. Sci. 2007, 96 (3), 644-660.
9. Löbenberg, R.; Shah, V.; Krämer, J.; Amidon, G. L.; Dressman, J. B. Dissolution testing as a prognostic tool for oral drug absorption: dissolution behavior of glibenclamide. Pharm. Res. 2000, 17 (4), 439-444.
10. Charman, W. N.; Porter, C. J.; Mithani, S.; Dressman, J. B. Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci. 1997, 86 (3), 269-282.
11. Galia, E. Physiologically based dissolution tests—Experiences with poorly soluble drugs. Ph.D. Dissertation, Johann Wolfgang Goethe University, Frankfurt, 1999.
12. Marques, M. Dissolution Media Simulating Fasted and Fed States. Dissolution Technol. 2004, 11 (2), 16.
13. Klein, S. Biorelevant Dissolution Test Methods for Modified Release Dosage Forms. Ph. D. Dissertation, Johann Wolfgang Goethe University, Frankfurt, 2005.
14. Carey, M. C.; Small, D. M. Micelle formation by bile salts. Physical-chemical and thermodynamic considerations. Arch. Intern. Med. 1972, 130 (4), 506-527.